Nakanoshima Qross Global Life Sciences Cluster
NQ Global Life Science Startup & Investment Connect vol.5
*Japanese follows.
A Special Program Connecting Global Startups, Investment Communities, and Business Opportunities
Building on the growing interest and opportunities for exchange generated by Expo 2025 Osaka, Kansai, this program aims to transform these connections from a one-time opportunity into continuous collaboration.
Through Nakanoshima Qross, we seek to foster an international life science innovation ecosystem and investment community that connects startups, investors, corporations, research institutions, and global innovation hubs.
The program will feature three events. In addition to introducing activities and initiatives by overseas life science clusters, promising Japanese startups will deliver pitches designed to facilitate new business matching and international collaboration among investors, corporations, and startups.
Event 1 - Global Ecosystem
【Event Details】
Date & Time : Tuesday, November 24, 2026, 6:30-6:50pm JST
Format : Online
Language : English (*Some announcements may be provided in Japanese.)
Speakers : WILCO
Who Should Attend :Life science and healthcare startups
VCs, CVCs, investors, and corporate investors
Companies in pharmaceuticals, medical devices, diagnostics, regenerative medicine, biomanufacturing, and digital health
Universities, research institutions, and healthcare organizations
Overseas life science clusters, accelerators, and support organizations
Companies and organizations interested in collaboration with startups, investment, joint research, business development, and international expansion
Organizer : Osaka Prefecture
Program Office : Organization of Future Medicine
Operational Partner : CIC Japan Innovation Services G.K.
Supporting Partner : Osaka Life Science Nexus by Nippon Life and CIC
Event 2 - Startup Pitch : Biotechnology & Drug Discovery
【Event Details】
Date & Time : Tuesday, November 24, 2026, 6:50-9:20 JST
Format : Online
Language : English (*Some announcements may be provided in Japanese.)
Speakers :Yo (Max)Amakusa, MBA / CEO of iBody Inc.
Ayan Sengupta / CEO of Myimmune Corporation
TBA
Who Should Attend :Life science and healthcare startups
VCs, CVCs, investors, and corporate investors
Companies in pharmaceuticals, medical devices, diagnostics, regenerative medicine, biomanufacturing, and digital health
Universities, research institutions, and healthcare organizations
Overseas life science clusters, accelerators, and support organizations
Companies and organizations interested in collaboration with startups, investment, joint research, business development, and international expansion
Organizer : Osaka Prefecture
Program Office : Organization of Future Medicine
Operational Partner : CIC Japan Innovation Services G.K.
Supporting Partner : Osaka Life Science Nexus by Nippon Life and CIC
Event 3 - Startup Pitch : Medical Devices & Digital Health
【Event Details】
Date & Time : Tuesday, November 24, 2026, 6:50-9:20 JST
Format : Online
Language : English (*Some announcements may be provided in Japanese.)
We're currently accepting applications from startups to present at the pitch event! Click here to apply.
Speakers:Masaya Miyazaki, Ph.D. / Founder & CEO of HaKaL inc.
Aoi Sasaki / Global Expansion Lead of Quadlytics Inc.
Hidenori Nakamura, MBA / Founder & CEO of atDose Co., Ltd.
TBA
Who Should Attend :Life science and healthcare startups
VCs, CVCs, investors, and corporate investors
Companies in pharmaceuticals, medical devices, diagnostics, regenerative medicine, biomanufacturing, and digital health
Universities, research institutions, and healthcare organizations
Overseas life science clusters, accelerators, and support organizations
Companies and organizations interested in collaboration with startups, investment, joint research, business development, and international expansion
Organizer : Osaka Prefecture
Program Office : Organization of Future Medicine
Operational Partner : CIC Japan Innovation Services G.K.
Supporting Partner : Osaka Life Science Nexus by Nippon Life and CIC
【Speakers' Detail】
- Yo (Max)Amakusa, MBA / CEO of iBody Inc.
Yo (Max) Amakusa is the CEO of iBody Inc., a biotechnology startup originating from Nagoya University, Japan. He has approximately 20 years of experience in the pharmaceutical and biotechnology industries, with a background in sales, marketing, business development, and strategic partnerships.
Before becoming CEO of iBody in March 2020, he held positions at Sumitomo Pharma, IQVIA, and a biotechnology venture, gaining extensive experience in pharmaceutical commercialization and business development.
At iBody, he leads corporate strategy, international business development, and strategic collaborations with pharmaceutical and diagnostic companies. Under his leadership, the company has expanded its business beyond Japan, actively building partnerships across the United States, Europe, and Asia.
He is passion